Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Botanix Pharmaceuticals Limited ( (AU:BOT) ).
UniSuper Limited, as a trustee for UniSuper and UniSuper Management Pty Limited, has become a substantial holder in Botanix Pharmaceuticals Limited as of April 24, 2025, with a 5.14% voting power through ownership of 100,455,466 ordinary shares. This acquisition indicates a significant investment in Botanix Pharmaceuticals, potentially impacting the company’s market positioning and signaling confidence in its strategic direction, which could influence other stakeholders and investors.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development of dermatology and antimicrobial products. The company is engaged in advancing novel therapies for skin diseases and infections, leveraging innovative drug delivery technologies to enhance treatment efficacy.
YTD Price Performance: -7.95%
Average Trading Volume: 9,877,096
Technical Sentiment Signal: Sell
Current Market Cap: A$791.3M
Find detailed analytics on BOT stock on TipRanks’ Stock Analysis page.